RenalGuard Solutions
MA - MilfordBiotechnology
Focus: RenalGuard Solutions develops a contrast dye-removal device focused on nephrology and cardiovascular disease prevention. The company is publicly traded and operates as a specialized biotech player with a narrow therapeutic focus.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About RenalGuard Solutions
AI assessmentNot HiringNo open roles listed right now. Follow RenalGuard Solutions to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Early-Stage
Sole marketed or lead-stage product with 1 ongoing trial but no clear revenue data disclosed.
Pipeline & Clinical Trials
RenalGuard
Cardiovascular DiseaseHelp build intelligence for RenalGuard Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.